← Fever Tree
What podcasts say about Fever Tree
Every statement, with the speaker, the exact quote and the moment it was said.
What experts have said about Fever Tree
4 statements · 2 positive · 2 negative
Fever-Tree is currently richly valued.
“Its valuation is very rich.”
Open the episode · IC033 Stonking Small Caps Release Good Results & Potential Tax ChangesListen at 28:56
Fever-Tree’s international growth story remains attractive, especially in the US.
“we still like the story and we think there are a lot of reasons to encourage specifically the US growth and the rest of the world.”
Open the episode · IC033 Stonking Small Caps Release Good Results & Potential Tax ChangesListen at 29:09
Fever-Tree’s full-year growth guidance has fallen from 10% to 4–5%.
“they've still guided, they were guiding for 10% growth. It's now going to be a lot less, 4 to 5%.”
Open the episode · IC033 Stonking Small Caps Release Good Results & Potential Tax ChangesListen at 30:19
Fever-Tree is performing strongly in the US market.
“Fever Tree, a rare AIM success in the US market, seems to be going great guns”
Open the episode · IC021 Investor Insights: Fund Managers, National Grid, Undervalued Stocks & Investment IdeasListen at 31:08
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.